Pulmonary Inflammation Induced by Subacute Ozone is Augmented in Adiponectin-deficient Mice: Role of IL-17A
Overview
Authors
Affiliations
Pulmonary responses to ozone, a common air pollutant, are augmented in obese individuals. Adiponectin, an adipose-derived hormone that declines in obesity, has regulatory effects on the immune system. To determine the role of adiponectin in the pulmonary inflammation induced by extended (48-72 h) low-dose (0.3 parts per million) exposure to ozone, adiponectin-deficient (Adipo(-/-)) and wild-type mice were exposed to ozone or to room air. In wild-type mice, ozone exposure increased total bronchoalveolar lavage (BAL) adiponectin. Ozone-induced lung inflammation, including increases in BAL neutrophils, protein (an index of lung injury), IL-6, keratinocyte-derived chemokine, LPS-induced CXC chemokine, and G-CSF were augmented in Adipo(-/-) versus wild-type mice. Ozone also increased IL-17A mRNA expression to a greater extent in Adipo(-/-) versus wild-type mice. Moreover, compared with control Ab, anti-IL-17A Ab attenuated ozone-induced increases in BAL neutrophils and G-CSF in Adipo(-/-) but not in wild-type mice, suggesting that IL-17A, by promoting G-CSF release, contributed to augmented neutrophilia in Adipo(-/-) mice. Flow cytometric analysis of lung cells revealed that the number of CD45(+)/F4/80(+)/IL-17A(+) macrophages and γδ T cells expressing IL-17A increased after ozone exposure in wild-type mice and further increased in Adipo(-/-) mice. The IL-17(+) macrophages were CD11c(-) (interstitial macrophages), whereas CD11c(+) macrophages (alveolar macrophages) did not express IL-17A. Taken together, the data are consistent with the hypothesis that adiponectin protects against neutrophil recruitment induced by extended low-dose ozone exposure by inhibiting the induction and/or recruitment of IL-17A in interstitial macrophages and/or γδ T cells.
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity.
Palma G, Sorice G, Genchi V, Giordano F, Caccioppoli C, DOria R Int J Mol Sci. 2022; 23(13).
PMID: 35806353 PMC: 9267094. DOI: 10.3390/ijms23137349.
Carnino J, Lee H, Smith L, Sunil V, Rancourt R, Vayas K Toxicol Sci. 2022; 187(1):162-174.
PMID: 35201360 PMC: 9041552. DOI: 10.1093/toxsci/kfac025.
Mechanisms contributing to adverse outcomes of COVID-19 in obesity.
Sudhakar M, Winfred S, Meiyazhagan G, Venkatachalam D Mol Cell Biochem. 2022; 477(4):1155-1193.
PMID: 35084674 PMC: 8793096. DOI: 10.1007/s11010-022-04356-w.
Adiponectin and Asthma: Knowns, Unknowns and Controversies.
Otelea M, Arghir O, Zugravu C, Rascu A Int J Mol Sci. 2021; 22(16).
PMID: 34445677 PMC: 8396527. DOI: 10.3390/ijms22168971.
Enweasor C, Flayer C, Haczku A Front Immunol. 2021; 12:631092.
PMID: 33717165 PMC: 7952990. DOI: 10.3389/fimmu.2021.631092.